Partnering with Calico
Our partnering philosophy
We’re not intimidated by bold ideas and risk, as we’re looking to take big leaps in the fields of aging and age-related disease. We like to collaborate with outstanding people and organizations that bring access to new biology and technology platforms. We won’t hesitate to explore unproven areas if the science and rationale are strong, and we’re not tied to specific pathways, targets or technologies.
We’re flexible in how we organize and structure partnerships. Our preference is to be deeply engaged scientifically in collaborative research programs.
SOME OF OUR KEY PARTNERSHIPS ARE DESCRIBED IN OUR PRESS RELEASES.
"External partnerships bring new ideas, perspectives, technologies and know-how to complex challenges. Calico prides itself on being an outstanding partner."
Why collaborate with Calico
Calico combines the focus and drive of a start-up with the resources and world class R&D capabilities of the leading biotechnology companies. Calico’s internal research efforts are predicated on “beyond state-of-the-art” technology and research infrastructure including advanced sequencing, computational biology and machine learning, metabolomics/proteomics, microscopy/imaging and translational biology.
Through our productive alliance with AbbVie, we have outstanding access to resources including medicinal chemistry, protein production, drug screening, and structural biology to accelerate development of therapeutic programs and discovery technologies. Partnering with Calico provides people, resources, and capabilities to advance a full range of biotechnology R&D opportunities.
Calico Stories
By studying DNA data from more than 200,000 research volunteers, scientists at Calico have contributed to a more comprehensive understanding of a key aging mechanism that affects…
Types of collaborations
We’re open to many different types of partnerships with various structures, if we believe they will advance our scientific pursuits.
We focus on the following types of collaborations:
-
01
Sponsored academic research, especially projects focused on understanding the basic biology of aging and hallmarks of aging such as proteostasis and repair, stress responses, cellular energetics and senescence; other interests for sponsored research include early drug discovery and genetic studies.
-
02
Licensing and collaboration agreements for pre-clinical and clinical-stage therapeutic programs, including, but not limited to cancer, neurodegeneration, chronic inflammation and metabolic disorders.
-
03
Novel drug and target discovery platforms in the areas of nucleic acid sequencing (including single cell methods and spatial transcriptomics), mass spectrometry, and imaging, to name a few.
-
04
Advanced technology and computing platforms and capabilities, including machine learning, and computer vision/perception.
We welcome proposals for partnership. If you would like to collaborate with Calico, please provide us with a brief non-confidential proposal that describes the opportunity, including scientific supporting data, to busdev@calicolabs.com
Our Collaborators
We work alongside exceptional partners whose expertise and technologies complement our own. Together, we’re pushing the boundaries of research and translational science, driving breakthroughs that could lead to meaningful clinical interventions that extend healthspans.
Learn more about Calico’s collaborations with leading industry and academic organizations.
Partnering with Calico
We welcome proposals for partnership. If you would like to collaborate with Calico, please complete the form below and provide us with a brief non-confidential summary of the opportunity.
"*" indicates required fields